Search This Blog

Tuesday, February 26, 2019

RedHill Biopharma reports FY18 revenue $8.4M, consensus $9.55M

Reports FY18 operating loss of $39.3M compared to $52M for FY17.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)